Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China flag China · Delayed Price · Currency is CNY
22.56
-0.01 (-0.04%)
Apr 29, 2026, 3:00 PM CST

SHA:600285 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,70511,66312,4809,6497,3588,920
Market Cap Growth
7.02%-6.54%29.34%31.14%-17.51%85.47%
Enterprise Value
12,27910,86411,5528,4826,3248,108
Last Close Price
22.5620.7121.3215.9311.7013.62
PE Ratio
16.2315.3617.2716.9815.8124.67
Forward PE
15.0213.5916.5016.4515.4315.43
PS Ratio
3.213.033.572.912.453.31
PB Ratio
3.453.394.053.452.883.90
P/TBV Ratio
4.474.514.353.733.144.37
P/FCF Ratio
19.6523.4716.4012.189.1111.60
P/OCF Ratio
18.0321.0614.2511.868.8110.55
EV/Sales Ratio
3.102.823.302.562.113.01
EV/EBITDA Ratio
12.5611.6414.5212.7613.6518.11
EV/EBIT Ratio
14.0812.9615.9614.4016.2521.54
EV/FCF Ratio
18.9921.8615.1910.717.8310.55
Debt / Equity Ratio
0.080.120.030.070.060.12
Debt / EBITDA Ratio
0.290.420.120.310.340.63
Debt / FCF Ratio
0.440.800.130.260.200.37
Net Debt / Equity Ratio
-0.13-0.04-0.46-0.49-0.51-0.41
Net Debt / EBITDA Ratio
-0.48-0.15-1.78-2.09-2.80-2.10
Net Debt / FCF Ratio
-0.72-0.29-1.86-1.75-1.60-1.22
Asset Turnover
0.700.720.720.730.740.74
Inventory Turnover
2.001.771.881.861.831.86
Quick Ratio
0.760.601.071.111.161.16
Current Ratio
1.171.081.311.371.471.48
Return on Equity (ROE)
22.57%23.40%24.58%21.21%19.21%15.73%
Return on Assets (ROA)
9.58%9.84%9.24%8.08%5.98%6.49%
Return on Invested Capital (ROIC)
23.30%29.32%41.04%38.32%26.85%21.97%
Return on Capital Employed (ROCE)
23.10%23.80%23.00%20.50%14.80%16.00%
Earnings Yield
6.21%6.51%5.79%5.89%6.32%4.05%
FCF Yield
5.09%4.26%6.10%8.21%10.98%8.62%
Dividend Yield
3.99%-4.22%5.02%5.13%3.67%
Payout Ratio
64.75%67.32%62.47%60.60%62.08%61.91%
Buyback Yield / Dilution
-0.59%-0.64%0.42%0.30%-0.26%0.24%
Total Shareholder Return
3.39%-0.64%4.64%5.33%4.87%3.91%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.